Veidekke ASA Share Price OTC Markets
Stocks
VDEK.F
NO0005806802
Construction & Engineering
OTC Markets Traded| Market Cap | 2.59TCr 260.87Cr 228.73Cr 210.84Cr 197.39Cr 370.13Cr 25TCr 377.82Cr 2.53TCr 980.56Cr 12TCr 979.57Cr 958.18Cr 42TCr | P/E 2026 * |
16.9x | P/E 2027 * | 15.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.3TCr 231.62Cr 203.09Cr 187.2Cr 175.26Cr 328.64Cr 22TCr 335.46Cr 2.25TCr 870.63Cr 11TCr 869.75Cr 850.76Cr 37TCr | EV / Sales 2026 * |
0.5x | EV / Sales 2027 * | 0.48x |
| Free-Float |
67.38% | Yield 2026 * |
5.83% | Yield 2027 * | 6.05% |
| 1 day | +0.12% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 01/09/2019 | |
| Director of Finance/CFO | 54 | 03/06/2010 | |
| Compliance Officer | 48 | 01/02/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Inge Ramsdal
BRD | Director/Board Member | 64 | 01/01/2008 |
| Director/Board Member | 70 | 01/01/2005 | |
Arve Fludal
BRD | Director/Board Member | 56 | 01/05/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.12% | -4.41% | - | - | 260.87Cr | |
| -4.28% | -2.05% | +81.27% | +261.07% | 10TCr | |
| -0.95% | +0.35% | +5.00% | +25.02% | 8.17TCr | |
| -8.10% | -5.75% | +259.29% | +1,051.70% | 6.52TCr | |
| +0.90% | +0.25% | +15.28% | +77.46% | 6.15TCr | |
| -1.40% | +0.70% | +35.25% | +113.80% | 4.99TCr | |
| -2.39% | -2.58% | +205.59% | +536.98% | 4.27TCr | |
| -0.93% | -1.99% | +120.90% | +312.18% | 3.87TCr | |
| -7.48% | -4.60% | +56.19% | +349.48% | 3.55TCr | |
| -0.90% | -4.56% | -24.53% | -22.67% | 2.67TCr | |
| Average | -2.54% | -1.36% | +83.80% | +300.56% | 5.61TCr | |
| Weighted average by Cap. | -2.93% | -0.85% | +85.50% | +306.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.59TCr 462.23Cr 405.29Cr 373.58Cr 349.75Cr 655.83Cr 44TCr 669.45Cr 4.49TCr 1.74TCr 22TCr 1.74TCr 1.7TCr 75TCr | 4.77TCr 480.56Cr 421.35Cr 388.39Cr 363.61Cr 681.83Cr 45TCr 695.99Cr 4.67TCr 1.81TCr 22TCr 1.8TCr 1.77TCr 78TCr |
| Net income | 152.52Cr 15Cr 13Cr 12Cr 12Cr 22Cr 1.45TCr 22Cr 149.31Cr 58Cr 716.61Cr 58Cr 56Cr 2.48TCr | 162.83Cr 16Cr 14Cr 13Cr 12Cr 23Cr 1.55TCr 24Cr 159.41Cr 62Cr 765.07Cr 62Cr 60Cr 2.65TCr |
| Net Debt | -290.2Cr -29Cr -26Cr -24Cr -22Cr -41Cr -2.76TCr -42Cr -284.1Cr -109.93Cr -1.36TCr -109.82Cr -107.42Cr -4.73TCr | -302.45Cr -30Cr -27Cr -25Cr -23Cr -43Cr -2.88TCr -44Cr -296.1Cr -114.57Cr -1.42TCr -114.46Cr -111.96Cr -4.93TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
